Use of RTS Vaccine as Prevention Malaria in Children

Nuning juni setia ningsih; Wulan Rahmadhani

doi:10.26753/jsrhs.v2i1.1024

Use of RTS Vaccine as Prevention Malaria in Children

Nuning juni setia ningsih, Wulan Rahmadhani

= https://doi.org/10.26753/jsrhs.v2i1.1024

Abstract views = 249 times |

views = 30 times

Abstract

Background:

Malaria cases are found almost all over the world, especially countries with tropical and subtropical climates, therefore, the population at risk for malaria is estimated at 2.3 billion or 41% of the world's population. As many as 35% of the world's population live in areas that are at risk of transmission of Plasmodium falciparum, and about 1 billion people live in areas that are at low risk and there is still transmission of Malaria.The purpose of this literature review is to analyze the results of a previous study on the use of the RTS vaccine for malaria prevention in children.

Method: The method used is a literature review. In the first stage, it starts by straightening the article usingsearch enginePubmed and Google scholar. The keywords used in the article search are" malaria, children, vaccines, RTS”.Results:From the article, it was found that the use of RTS vaccine to prevent the incidence of malaria is a promising approach considering the increasing number of drug resistance. This vaccine has an efficacy of 80% for the prevention of parasite invasion in the preerythrocytic stage. Conclusion: The use of RTS vaccine is effective for malaria prevention efforts.

Full Text:

PDF

References

Guinovart, “Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children,” PLoS One, vol. 4, 2019.

Ubillos, “Development of a highthroughput flexible quantitative suspension array assay for IgG against multiple Plasmodium falciparum antigens,” J. Malar., vol. 17, 2018.

WHO, “Monitoring Health for the SDGs, Sustainable Development Goals. Ganeva: World Health Organization; 2019.,” 2019.

World Health Organization, “Monitoring Health for The SDGs,” 2017.

Kemenkes RI, “Riset Kesehatan Dasar,” 2018.

Chandramohan, “Effect of adding azithromycin to seasonal malaria chemoprevention,” New Engl. J., vol. 112, 2019.

DEPKES RI, “Klasifikasi umur menurut kategori,” 2019. .

Cairns, “Analysis of preventive interventions for malaria: exploring partial and complete protection and total and primary intervention effects,” Am J Epidemiol, vol. 151, 2015.

Jeitao, “Revising the who verbal autopsy instrument to facilitate routine cause- of- death monitoring,” Glob Heal. Action, 2013.

Neafsey, “Genetic diversity and protective efficacy of the RTS,S/AS01 malaria vaccine.,” New Engl. J., vol. 373, 2015.

Campo, “vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites,” Mol Cell Proteomics, vol. 14, 2015.

Swysen, “Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine,” J. Malar., 2015.

Moncunill, “Distinct helper T cell type 1 and 2 responses associated with malaria protection and risk in RTS,S/AS01E vaccinees,” Clin Infect Dis, vol. 65, 2017.

Piaggio, “Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement,” JAMA, vol. 295, 2016.

Vidal, “Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens,” J Immunol Methods, vol. 455, 2018.

R. F. Aniroh, U., & Fatimah, “Tingkat Kecemasan Ibu Primigravida dalam Menghadapi Persalinan Ditinjau dari Usia Ibu dan Sosial Ekonomi,” J. Ilmu Keperawatan Matern., vol. 2, no. 2, 2019.

Olotu, “Individual-participant pooled analysis of phase 2 data,” Lancet Infect Dis, vol. 3, no. 4, 2013.

Reiter K, Shimp LR, Kotova S, Smith PD, Hurt DE, et al. 2009. Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. JBC Papers in Press. 284(39):26951–26963.